The Regression of Liver Fibrosis and Risk for Hepatocellular Carcinoma (ROLFH) Study

This study is not yet open for participant recruitment.
Verified November 2013 by University of Arkansas
Sponsor:
Collaborators:
University of North Carolina, Chapel Hill
University of Toronto
University of Calgary
Information provided by (Responsible Party):
University of Arkansas
ClinicalTrials.gov Identifier:
NCT01831037
First received: April 2, 2013
Last updated: November 12, 2013
Last verified: November 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is not yet open for participant recruitment.
  Estimated Study Completion Date: December 2018
  Estimated Primary Completion Date: June 2018 (Final data collection date for primary outcome measure)